By vgreene, 28 January, 2021 F U q2 6wk to achieve control then q1 6mo to monitor control q3mo if step down tx anticipated
By vgreene, 28 January, 2021 If clear benefit sustained 3mo consider step down to assess ongoing need for daily tx pts this age have high spontaneous remission rates
By vgreene, 28 January, 2021 If no clear benefit observed 4 6wk from initial tx consider d c ing or adjusting tx or alternative dx
By vgreene, 28 January, 2021 If alternative tx used switch to preferred tx for current step If side effects consider alternative tx
By vgreene, 28 January, 2021 Step up at 1 tx step for not well controlled dz 1 1st review adherence inhaler technique environment control
By vgreene, 28 January, 2021 Every visit reinforce sx monitoring action plan if hx of severe exacs include PO steroids inhaler device technique quick relief vs controller meds med adherence environment control based on sx related to exposure
